AI assistant
Sending…
CONMED Corp — Director's Dealing 2011
Nov 1, 2011
31971_dirs_2011-11-01_671304a1-a101-42b2-9a7c-2766058c8f7d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2011-10-28
Reporting Person: CORASANTI EUGENE R (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-10-28 | Common Stock | M | 62500 | $19.93 | Acquired | 130803 | Direct |
| 2011-10-28 | Common Stock | F | 51851 | $25.94 | Disposed | 78952 | Direct |
| 2011-10-28 | Common Stock | S | 10649 | $26.1242 | Disposed | 68303 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-10-28 | Sars (Stock Appreciation Rights) | $19.93 | M | 62500 | Disposed | 2016-05-16 | Common Stock (62500) | Direct |
Footnotes
F1: The stock appreciation rights ("SARs") were granted under the Issuer's 2006 Stock Incentive Plan and generally vest in equal
amounts over a five year period.
More from CONMED Corp
Regulatory Filings
2026
Jun 1
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 20
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Regulatory Filings
2026
Apr 29
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7
Proxy Solicitation & Information Statement
2026
Apr 7